Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)
| 3.22 Delayed Data As of 3:59pm ET |  -0.28 / -8.00%Today’s Change | 2.55 Today|||52-Week Range 8.83 | -46.69% Year-to-Date |
Latest ZYNE News | Press Releases
| Zynerba Pharmaceuticals (ZYNE) Investor Presentation - Slideshow Sep 18 / Seeking Alpha - Paid Partner Content | Zynerba's cannabidiol an Orphan drug for a rare chromosomal disorder Sep 17 / Seeking Alpha - Paid Partner Content |
| Zynerba Pharmaceuticals (ZYNE) Jumps: Stock Rises 7.7% Sep 18 / Zacks.com - Paid Partner Content | Zynerba Pharmaceuticals provides update on recent milestones Sep 14 / Seeking Alpha - Paid Partner Content |
| Making The Case For Zynerba Pharmaceuticals Sep 17 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 3.50 |
| Today’s open | 3.47 |
| Day’s range | 3.20 - 3.50 |
| Volume | 33,246 |
| Average volume (3 months) | 1,405,164 |
| Market cap | $108.2M |
Data as of 3:59pm ET, 09/23/2020
Growth & Valuation
| Earnings growth (last year) | +42.56% |
| Earnings growth (this year) | -41.62% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.14 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LPCNLipocine Inc | -0.14 | -8.77% |
| --Ecogreen Internation... | -0.00 | -0.76% |
| AIMAIM ImmunoTech Inc | -0.29 | -11.42% |
| CAPRCapricor Therapeutic... | -0.19 | -3.60% |
Data as of 4:03pm ET, 09/23/2020
Financials
| Next reporting date | November 17, 2020 |
| EPS forecast (this quarter) | -$0.43 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$32.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Devon, Pennsylvania |
Forecasts
